Transaction · 0002071953-26-000007

Spetzler David Baxley

Spetzler David Baxley, PRES, reported an open-market or private sale at Caris Life Sciences, Inc. involving 393100.000000 shares for an estimated $9733313.24. Reported holdings after the transaction were 1136983.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SPRES
CAICaris Life Sciences, Inc.
Trade date
Sep 03, 2026
Filing date
Sep 04, 2026
View on SEC Insider profile
Estimated value-$9.73MShares × reported price
Shares traded393k$24.76 per share
Holdings after1.13MDirect
% of reported position traded25.69%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,530,083 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CAI price since this filing

Daily closing prices, with the filing date and available return windows
CAI · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -36.4%1w ago +4.2%1d ago -2.1%
Returns since7d -3.9%30d +11.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002071953-26-000007
Common Stock
Transaction date
Sep 03, 2026
Filed Sep 04, 2026, 08:59 PM · 1d delay
Shares
393,100 sh
$24.76 per share
Estimated value
-$9.73M
Computed from shares × price
Holdings after
1,136,983 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Reduction Large Sale
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested stock options scheduled to expire on September 12, 2026. The shares were sold solel…

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.3200 to $25.3100, inclusive. The reporting person undertakes to p…

  3. F3

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.3200 to $25.3300, inclusive. The reporting person undertakes to p…

  4. F4

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.5550 to $25.1200, inclusive. The reporting person undertakes to p…

  5. F5

    Exercise of stock options before their expiration date.

  6. F6

    The stock option is fully vested and exercisable.

Original filing · 0002071953-26-000007
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CAI